DETECT research study
We’re sorry! We’re no longer enrolling participants in our DETECT study. You can still learn about the study by reading below.
What is DETECT?
Detecting Cancers Earlier Through Elective Mutation-Based Blood Collection and Testing (DETECT) is a research study that is trying to understand how well a blood test works for finding cancer. DETECT uses a research marker panel blood test to look for tumor DNA by checking for 15 genes and look for abnormally high levels of 10 protein markers.
How many people were recruited for DETECT?
- Enrollment target: 10,000 patients
- Current enrollment: 10,006 (we met our target enrollment goal in May 2019)
Where did this study take place?
- Geisinger Bloomsburg Hospital, Professional Building
- Geisinger Medical Center (Danville, PA)
- Geisinger Precision Health Clinic (Forty-Fort, PA)
- Geisinger Grays Woods (Port Matilda, PA)
- Geisinger Mount Pocono
- Geisinger Lewistown
- Geisinger Tunkhannock
- Miller Center (Lewisburg, PA)
- Geisinger Hazleton
- Tiadaghton Health Center (Lock Haven, PA)
- Geisinger South Williamsport
- Geisinger Pottsville
- Geisinger South Wilkes Barre
- Geisinger Shamokin Hospital
- Scranton, PA